Literature DB >> 21148755

The epidemiology of oral HPV infection among a multinational sample of healthy men.

Aimee R Kreimer1, Alessandro Villa, Alan G Nyitray, Martha Abrahamsen, Mary Papenfuss, Danelle Smith, Allan Hildesheim, Luisa L Villa, Eduardo Lazcano-Ponce, Anna R Giuliano.   

Abstract

BACKGROUND: Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men.
METHODS: Oral rinse/gargle specimens and questionnaire data were collected from 1,688 healthy men aged 18 to 74 (median = 31 years), from the United States, Mexico, and Brazil. HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59, and noncarcinogenic HPV types were detected using Roche Linear Array.
RESULTS: Oral HPV DNA was detected in 67 of 1,680 (4.0%, 95% CI = 3.1%-5.0%) β-globin-positive specimens; carcinogenic HPVs were detected in 1.3% (95% CI = 0.8%-2.0%; n = 22) and HPV16 was the most commonly detected carcinogenic HPV type (0.6%, 95% CI = 0.2%-1.1%; n = 10). The prevalence of oral HPV infection was similar by country except for HPV55, which had notably higher prevalence in Mexico (3.0%) than Brazil (0%) or the United States (0.2%). Oral HPV prevalence nonsignificantly increased over increasing age categories (P(trend) = 0.096). The strongest predictor of oral HPV was current tobacco use, which increased the odds 2.5-fold (95% CI = 1.4-4.4). Oral sexual behaviors were not associated with oral HPV infection.
CONCLUSIONS: Oral HPV16 infection was rare in healthy men, especially at younger ages, and was positively associated with current tobacco use. IMPACT: Oral HPV appears to be about 10-fold less prevalent than infection at genital sites in men (4% vs. ∼40%, respectively). It remains unclear whether this reflects reduced exposure or if the oral region is more resistant to HPV infection compared with anogenital sites. ©2011 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 21148755      PMCID: PMC3027138          DOI: 10.1158/1055-9965.EPI-10-0682

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  29 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 2.  Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel.

Authors:  W Cates
Journal:  Sex Transm Dis       Date:  1999-04       Impact factor: 2.830

3.  Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia.

Authors:  X Castellsagué; A Ghaffari; R W Daniel; F X Bosch; N Muñoz; K V Shah
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

Review 4.  Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.

Authors:  Aimee R Kreimer; Gary M Clifford; Peter Boyle; Silvia Franceschi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

5.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.

Authors:  Philip E Castle; Sholom Wacholder; Attila T Lorincz; David R Scott; Mark E Sherman; Andrew G Glass; Brenda B Rush; John E Schussler; Mark Schiffman
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

Review 7.  Oral human papillomavirus in healthy individuals: a systematic review of the literature.

Authors:  Aimée R Kreimer; Rohini K Bhatia; Andrea L Messeguer; Paula González; Rolando Herrero; Anna R Giuliano
Journal:  Sex Transm Dis       Date:  2010-06       Impact factor: 2.830

8.  Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus.

Authors:  Aimee R Kreimer; Anthony J Alberg; Richard Daniel; Patti E Gravitt; Rapheal Viscidi; Elizabeth S Garrett; Keerti V Shah; Maura L Gillison
Journal:  J Infect Dis       Date:  2004-02-02       Impact factor: 5.226

Review 9.  Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.

Authors:  Xavier Castellsagué; Nubia Muñoz
Journal:  J Natl Cancer Inst Monogr       Date:  2003

10.  Prevalence and determinants of human papillomavirus genital infection in men.

Authors:  S Franceschi; X Castellsagué; L Dal Maso; J S Smith; M Plummer; C Ngelangel; S Chichareon; J Eluf-Neto; K V Shah; P J F Snijders; C J L M Meijer; F X Bosch; N Muñoz
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

View more
  71 in total

1.  Sexual transmission of oral human papillomavirus infection among men.

Authors:  Kristina R Dahlstrom; Ann N Burchell; Agnihotram V Ramanakumar; Allita Rodrigues; Pierre-Paul Tellier; James Hanley; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-12       Impact factor: 4.254

2.  Response from Dr. Cleveland and colleagues.

Authors: 
Journal:  J Am Dent Assoc       Date:  2012-05       Impact factor: 3.634

Review 3.  Epidemiology and clinical aspects of HPV in head and neck cancers.

Authors:  Anil K Chaturvedi
Journal:  Head Neck Pathol       Date:  2012-07-03

4.  Smoking increases oral HPV persistence among men: 7-year follow-up study.

Authors:  K Kero; J Rautava; K Syrjänen; J Willberg; S Grenman; S Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-13       Impact factor: 3.267

Review 5.  Discussing the diagnosis of HPV-OSCC: common questions and answers.

Authors:  Carole Fakhry; Gypsyamber D'Souza
Journal:  Oral Oncol       Date:  2013-07-19       Impact factor: 5.337

6.  Diversity of beta-papillomavirus at anogenital and oral anatomic sites of men: The HIM Study.

Authors:  Emily Montosa Nunes; Staci L Sudenga; Tarik Gheit; Massimo Tommasino; Maria Luiza Baggio; Silvaneide Ferreira; Lenice Galan; Roberto C Silva; Christine M Pierce Campbell; Eduardo Lazcano-Ponce; Anna R Giuliano; Luisa L Villa; Laura Sichero
Journal:  Virology       Date:  2016-05-07       Impact factor: 3.616

7.  Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners.

Authors:  Gypsyamber D'Souza; Neil D Gross; Sara I Pai; Robert Haddad; Karen S Anderson; Shirani Rajan; Jennifer Gerber; Maura L Gillison; Marshall R Posner
Journal:  J Clin Oncol       Date:  2014-04-28       Impact factor: 44.544

8.  Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults.

Authors:  Daniel C Beachler; Elizabeth A Sugar; Joseph B Margolick; Kathleen M Weber; Howard D Strickler; Dorothy J Wiley; Ross D Cranston; Robert D Burk; Howard Minkoff; Susheel Reddy; Weihong Xiao; Yingshi Guo; Maura L Gillison; Gypsyamber D'Souza
Journal:  Am J Epidemiol       Date:  2014-12-04       Impact factor: 4.897

9.  Oral health and human papillomavirus-associated head and neck squamous cell carcinoma.

Authors:  Angela L Mazul; James M Taylor; Kimon Divaris; Mark C Weissler; Paul Brennan; Devasena Anantharaman; Behnoush Abedi-Ardekani; Andrew F Olshan; Jose P Zevallos
Journal:  Cancer       Date:  2016-08-29       Impact factor: 6.860

10.  Rates and determinants of oral human papillomavirus infection in young men.

Authors:  Zoe R Edelstein; Stephen M Schwartz; Stephen Hawes; James P Hughes; Qinghua Feng; Michael E Stern; Sandra O'Reilly; Shu-Kuang Lee; Long Fu Xi; Laura A Koutsky
Journal:  Sex Transm Dis       Date:  2012-11       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.